Watch our October 2020 briefing, Counterfeit Medicine: Crime and Policy 2020, a summary of the major cases we've seen this year, the trends that worry us, and current drug supply chain policy issues, followed by a ten minute Q&A session with PSM Executive Director Shabbir Imber Safdar.
Today, PhRMA, The Partnership for Safe Medicines and Council for Affordable Health Coverage initiated litigation in the U.S. District Court for the District of Columbia challenging action by HHS and FDA permitting pharmacists and wholesalers, pursuant to state-sponsored programs, to import certain prescription drugs from Canada into the United States without drug manufacturers’ authorization or oversight.
In PSM’s round-up this week: Government authorities take legal action against COVID scammers; an insurance broker (allegedly) decided to open his own unlicensed pharmacy; ongoing counterfeit medicine news, and more.
In PSM’s round-up this week: An analysis of New Mexico’s draft drug importation plan, reports on COVID-19 fraud, and this week in counterfeit medicine news.
The state of New Mexico released a draft of its Canadian drug importation plan. PSM analyzed the plan, paying particular attention to concerns pharmacists might have about how drug importation might affect their patients and business…
In PSM’s round-up this week: FDA and FTC warnings over fake COVID-19 treatments and fraud, as well as fake medicine news in seven U.S. states, Canada and Cambodia.